Inhibition of endocannabinoid synthesis enzymes DAGL and NAPE-PLD transiently lowers body weight and alters glucose homeostasis during a high-fat diet challenge in mice

Eenige, R. van; Sánchez López, E.; Hoekstra, A.T.; Ying, Z.X.; Boon, M.R.; Mock, E.D.; Giera, M.; Stelt, M. van der; Rensen, P.C.N.; Kooijman, S.

doi:doi:10.1093/ejendo/lvaf212

Background Cannabinoid receptor 1 inhibition poses an effective treatment strategy in obesity, but has a risk of psychiatric side effects. As high-fat diet (HFD)-feeding acutely increases expression of endocannabinoid synthesis enzymes and circulating endocannabinoid levels in mice, here we tested whether inhibition of these enzymes alleviates metabolic disturbances caused by high-fat diet feeding.Methods C57BL/6J mice received daily intraperitoneal injections with a NAPE-PLD inhibitor (LEI-401), DAGL inhibitor (DH-376), or vehicle for 1 week while on a HFD. An extra group of vehicle-treated mice was maintained on regular chow diet.Results Both inhibitors effectively lowered blood and brain levels of endocannabinoids after 1 week of treatment. DH-376 reduced plasma insulin levels compared with vehicle (-53%) already within 2 h after the first dose. In contrast, LEI-401 did not change insulin or glucose levels. Both inhibitors suppressed caloric intake during the first day of...Show moreBackground Cannabinoid receptor 1 inhibition poses an effective treatment strategy in obesity, but has a risk of psychiatric side effects. As high-fat diet (HFD)-feeding acutely increases expression of endocannabinoid synthesis enzymes and circulating endocannabinoid levels in mice, here we tested whether inhibition of these enzymes alleviates metabolic disturbances caused by high-fat diet feeding.Methods C57BL/6J mice received daily intraperitoneal injections with a NAPE-PLD inhibitor (LEI-401), DAGL inhibitor (DH-376), or vehicle for 1 week while on a HFD. An extra group of vehicle-treated mice was maintained on regular chow diet.Results Both inhibitors effectively lowered blood and brain levels of endocannabinoids after 1 week of treatment. DH-376 reduced plasma insulin levels compared with vehicle (-53%) already within 2 h after the first dose. In contrast, LEI-401 did not change insulin or glucose levels. Both inhibitors suppressed caloric intake during the first day of treatment (-25% and -21%, respectively). In addition, LEI-401 elevated carbohydrate oxidation. The combined effect was a 2.0 and 1.6 g lower body weight after 24 h, respectively. Nevertheless, after 1 week body weight was no longer different between the HFD-fed groups. Moreover, DH-376 increased brown adipose tissue weight and reduced insulin-stimulated glucose uptake.Conclusions DAGL and NAPE-PLD inhibition effectively lower levels of endocannabinoids and related bioactive lipids. Both inhibitors caused a transient reduction in food intake and body weight, but also led to alterations in glucose homeostasis. The long-term effects of endocannabinoid biosynthesis inhibitors on (cardio)metabolic health remains to be investigated.Show less

Leiden University Scholarly Publications

View statistics

Documents

In Collections

Inhibition of endocannabinoid synthesis enzymes DAGL and NAPE-PLD transiently lowers body weight and alters glucose homeostasis during a high-fat diet challenge in mice